Literature DB >> 526304

In vitro and in vivo studies with adriamycin liposomes.

E A Forssen, Z A Tökes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 526304     DOI： 10.1016/0006-291x(79)91207-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  14 in total

1.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Authors:  D Papahadjopoulos; T M Allen; A Gabizon; E Mayhew; K Matthay; S K Huang; K D Lee; M C Woodle; D D Lasic; C Redemann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Pharmacokinetics and antitumor effect of doxorubicin carried by stealth and remote loading proliposome.

Authors:  J P Wang; Y Maitani; K Takayama; T Nagai
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

3.  Delivery of therapeutic doses of doxorubicin to the mouse lung using lung-accumulating liposomes proves unsuccessful.

Authors:  R M Abra; C A Hunt; K K Fu; J H Peters
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 4.  A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles.

Authors:  D N Waterhouse; P G Tardi; L D Mayer; M B Bally
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 5.  Cancer nanomedicines: so many papers and so few drugs!

Authors:  Vincent J Venditto; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

Review 6.  Nanomedicine--challenge and perspectives.

Authors:  Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 7.  Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.

Authors:  Folefac Aminkeng; Colin J D Ross; Shahrad R Rassekh; Soomi Hwang; Michael J Rieder; Amit P Bhavsar; Anne Smith; Shubhayan Sanatani; Karen A Gelmon; Daniel Bernstein; Michael R Hayden; Ursula Amstutz; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2016-06-30       Impact factor: 4.335

Review 8.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes.

Authors:  A Rahman; A Ganjei; J R Neefe
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.

Authors:  E A Forssen; Z A Tökès
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.